C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
12/1999
12/09/1999	WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/08/1999	CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
11/1999
11/11/1999	WO1999057127A1 2'-deoxy hygromycin derivatives
11/11/1999	WO1999057125A2 Hygromycin a derivatives
11/11/1999	WO1999048901A3 Sucrose-n-alkyl-asparaginates, production and use thereof
11/03/1999	EP0535200B1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
10/1999
10/19/1999	US5969116 Ribo-nucleoside analogues the 2'-oh group etherified, and having a radical forming a phosphorous or ether-containing nucleotide bridge group, capable of base pairing with a complementary nucleic acid strand; binding affinity
10/12/1999	CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
09/1999
09/30/1999	WO1999048901A2 Sucrose-n-alkyl-asparaginates, production and use thereof
09/30/1999	CA2325396A1 Sucrose-n-alkyl-asparaginates, production and use thereof
09/21/1999	US5955425 Parathyroid hormone analogues for the treatment of osteoporosis
09/15/1999	EP0941243A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
09/14/1999	US5952334 Carbocyclic compounds
08/1999
08/26/1999	WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
08/19/1999	WO1999041265A1 Novel substances kf-1040 and process for producing the same
08/11/1999	EP0934328A1 Fabric softening composition
08/05/1999	WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/05/1999	CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use
08/04/1999	EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/1999
07/13/1999	US5922867 Method and compositions for the synthesis of dioxolane nucleosides with β configuration
07/13/1999	US5922580 Contacting a reducing partial starch hydrolysate with a novel enzyme which forms a non-reducing saccharide in the absence of trehalose; glucoamylase and glycosidase yield trehalose when allowed to act on the non-reducing saccharide
05/1999
05/27/1999	WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/19/1999	EP0915880A1 Azolo triazines and pyrimidines
04/1999
04/28/1999	EP0295248B2 Liposome preparation and antibiotic
04/22/1999	WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer
04/15/1999	WO1998056761A3 Benzimidazole derivatives
03/1999
03/18/1999	WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999	CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
02/1999
02/25/1999	WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity
02/17/1999	CN1208414A Method and compositions for the synthesis of dioxolane nucleosides with 'beta'-configuration
02/10/1999	EP0763133A4 Method for detecting a target nucleic acid
12/1998
12/29/1998	US5854280 Antifungal sordaridin derivatives
12/23/1998	CN1202903A Targeted cytotoxic anthracycline analogs
12/17/1998	WO1998056761A2 Benzimidazole derivatives
12/01/1998	US5843903 Targeted cytotoxic anthracycline analogs
11/1998
11/11/1998	EP0597915B1 A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
10/1998
10/22/1998	WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/08/1998	WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
09/1998
09/16/1998	EP0863917A1 Targeted cytotoxic anthracycline analogs
09/16/1998	CN1193357A Oligonucleotide tags for sorting and identification
09/08/1998	US5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria
09/02/1998	CN1192217A 磁性色素 Magnetic pigment
07/1998
07/15/1998	EP0712273A4 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures
07/07/1998	US5776911 Use of (S)-adenosyl-l-methionine (same) and its physiologically tolerated salts for treating reperfusion damage caused by temporary focal ischemia
06/1998
06/23/1998	US5770579 Erythromycin compounds
06/03/1998	CN1183812A Detection of biomolecules
05/1998
05/05/1998	US5747462 Pharmaceutically active compounds and their use
04/1998
04/30/1998	WO1998017686A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/30/1998	CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use
04/29/1998	EP0837871A1 Magnetic pigment
04/28/1998	US5744495 Immunomodulatory agents
04/23/1998	WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
04/23/1998	WO1998016538A1 Fabric softening composition
04/23/1998	CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
02/1998
02/10/1998	US5716838 Culture of microorganisms such as rhizobium, arthrobacter
01/1998
01/29/1998	WO1998003510A1 Azolo triazines and pyrimidines
01/14/1998	EP0818459A2 Carbohydrate derivatives
01/06/1998	US5705489 Having antithrombotic activity
01/06/1998	CA2084875C Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
10/1997
10/14/1997	US5677439 Prevention gene expression
10/07/1997	CA2009637C Substituted-1,3-oxathiolanes with antiviral properties
09/1997
09/10/1997	EP0675724B1 Use of dideoxy nucleoside analogues in the treatment of viral infections
08/1997
08/19/1997	CA2085503C Process for preparing 2-chloro-2'-deoxyadenosine
07/1997
07/22/1997	US5650271 Primers and templates, extenders and hybrids
07/02/1997	EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections
06/1997
06/19/1997	WO1997021706A1 METHOD AND COMPOSITIONS FOR THE SYNTHESIS OF DIOXOLANE NUCLEOSIDES WITH β-CONFIGURATION
06/05/1997	WO1997019954A1 Targeted cytotoxic anthracycline analogs
06/03/1997	USRE35524 Antitumor agents
06/03/1997	US5635400 Minimally cross-hybridizing sets of oligonucleotide tags
06/03/1997	CA2143204C Use of dideoxy nucleoside analogues in the treatment of viral infections
05/1997
05/28/1997	EP0671918B1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
05/07/1997	EP0771202A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
04/1997
04/17/1997	DE19537985A1 Magnetic particles with glass surface
04/16/1997	EP0767664A2 Combination therapy for hiv infection
04/16/1997	EP0514515B1 Anthracycline-conjugates
04/16/1997	EP0502180B1 Enzymatic synthesis of oligonucleotides
04/15/1997	US5621087 Analgesics
04/02/1997	EP0765665A1 Use of dideoxy nucleoside analogues in the treatment of viral infections
03/1997
03/25/1997	US5614470 13-substituted milbemycin derivatives, their preparation and their use
03/19/1997	EP0763133A1 Method for detecting a target nucleic acid
03/11/1997	US5610047 Trehalose
02/1997
02/26/1997	CN1143965A Carbocyclic compound
02/19/1997	CN1034054C Preparing method for improved oligosaccharide conjugate vaccines
02/05/1997	CN1033974C Process for preparing erythromycin derivatives
01/1997
01/14/1997	US5594155 Anomeric fluororibosyl amines
01/07/1997	US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections
12/1996
12/27/1996	WO1996041811A1 Magnetic pigment
12/27/1996	CA2607563A1 Magnetic particles with a glass surface and their use
12/27/1996	CA2605671A1 Magnetic particles with a glass surface and their use
12/25/1996	CN1033640C 2-substituted-5-substituted-1, 3-oxathiolanes with antiviral properties
12/19/1996	CA2332731A1 Oligonucleotide tags for sorting and identification
12/12/1996	DE19520398A1 Magnetic particles with, opt. porous, glass surface
11/1996
11/26/1996	US5578582 Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives
11/12/1996	US5573772 Methods for protecting tissues and organs from ischemic damage
10/1996
10/01/1996	US5561118 Antibiotics
09/1996
09/24/1996	US5559104 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
09/06/1996	CA2213622A1 Detection of biomolecules

1 2 3 4 5 6 7 8 9 10 11 12